← FDA DRUG APPROVALS

FDA ANDA · ANDA207358

ACETYLCYSTEINE

Sponsor: EUGIA PHARMA

APPLICATION
ANDA207358
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-29
LATEST ACTION
2020-12-16
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ACETYLCYSTEINEPrescription
ACETYLCYSTEINE 6GM/30ML (200MG/ML) · INJECTABLE · INTRAVENOUS

Approval history

2020-12-16Labeling · Supplement 1 · standardAP
2016-02-29UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →